FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status

Presented By

Prof. Gerasimos Filippatos , Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD, FIGARO-DKD

Conference

HFA 2022

28 July, 2022 12:09

Antagonising the mineralocorticoid receptor beneficial for patients with diabetes and CKD

Presented By

Prof. Bertram Pitt, University of Michigan School of Medicine, USA

Trial

Phase 3, FIGARO-DKD

Conference

ESC 2021

26 October, 2021 12:40

Presented By

Dr Rachel Giles, Medicom

Trial

EMPEROR-Preserved, ENVISAGE-TAVI, TOMAHAWK, FIGARO-DKD, FIDELITY, STEP, GUIDE-HF

Conference

ESC 2021

14 September, 2021 20:32